NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page

Neuro-Bio’s CEO participates at the 8th EAN Congress in Vienna.

On Saturday the 25th of June, Neuro-Bio’s CEO Susan Greenfield, will speak at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be “Where Neuroscience meets neurology: blowing, expanding, and losing the mind”.

To watch the EAN 2022 Opening Lecture Teaser, click the link.

To have more information about the congress, click the link.

 

 

LATEST NEWS

  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
  • CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
  • Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!
  • Our CSO Sara Garcia Rates & Project Development Manager, Bethany Watkinson, will be attending the MediWales (BioWales) event on Thursday 5th February
  • Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield is attending the “Inspire and Innovate with wise+ (Women in Innovation, Science & Engineering)” at the Novartis Basel Campus

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025